Drs Camidge and Kelley discuss the ways Dr Kelley’s passion for research guided his early career path.
How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life’s experiences.
In this episode, Dr Camidge sits down with Michael Kelley, MD, to discuss the many facets of Dr Kelley’s career. Dr Kelley is a professor of medicine in the Department of Medicine at the Duke University School of Medicine, as well as a member of the Duke Cancer Institute in Durham, North Carolina. He is also the chief of Hematology/Oncology at the Durham Veterans Affairs (VA) Medical Center and the executive director of the National Oncology Program at the Department of Veterans Affairs.
Drs Camidge and Kelley discuss the ways Dr Kelley’s passion for research guided his early career path, the benefits of surrounding oneself with motivating and innovative colleagues, the importance of perseverance when searching for one’s place in medicine, the details of providing cancer care through VA medical center facilities, and more.
Capivasertib/Fulvestrant Improves PFS2 in Pretreated PIK3CA/AKT1/PTEN+ HR+/HER2– Breast Cancer
T-DXd Maintains Survival Advantage Over Physician’s Choice of Therapy in HER2+ Metastatic Breast Cancer
Ipatasertib/Anti-HER2 Therapy Is Safe and Active in PIK3CA-Mutant, HER2+ Advanced Breast Cancer
Dato-DXd Reduces High-Grade TRAEs vs Chemo in Pretreated, HR+/HER2– Advanced Breast Cancer
2 Commerce Drive
Cranbury, NJ 08512